AVAI (Avai Bio) Forward Dividend Yield %: 0.00% (As of Jun. 29, 2026)


AVAI Avai Bio Inc AVAI
24 GF Score
Price $0.15
! 3 Warning Signs
View Full Analysis

What is Avai Bio Forward Dividend Yield %?

Avai Bio AVAI -3.77% 24 Forward Dividend Yield % is 0.00% as of Jun. 29, 2026. GuruFocus rates AVAI with a GF Score™ of 24/100. The stock has 3 warning signs investors should review. Among 999 Software companies, Avai Bio ranks worse than 100100% on this metric.

As of today (2026-06-29), the Forward Annual Dividend Yield of Avai Bio is 0.00%.

As of today (2026-06-29), the Trailing Annual Dividend Yield of Avai Bio is 0.00%.

AVAI's Forward Dividend Yield % is not ranked *
in the Software industry.
Industry Median: 2.55
* Ranked among companies with meaningful Forward Dividend Yield % only.

Avai Bio's Dividends per Share for the three months ended in Dec. 2025 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Avai Bio  (OTCPK:AVAI) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Avai Bio Forward Dividend Yield % Related Terms

AVAI vs IPM, RCT, LPSN: Forward Dividend Yield % Comparison

For the Software - Application subindustry, Avai Bio's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avai Bio Forward Dividend Yield % vs Software Industry

For the Software industry and Technology sector, Avai Bio's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Avai Bio's Forward Dividend Yield % falls into.


AVAI
24GF Score
Avai Bio Inc AVAI
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avai Bio Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Avai Bio (AVAI) has a Forward Dividend Yield % of 0.00% as of Jun. 29, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Avai Bio and its competitors. According to the industry distribution chart, Avai Bio ranks #999999 out of 999 companies in the Software industry.
Is Avai Bio's Forward Dividend Yield % too high?
Avai Bio's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Avai Bio ranks #999999 out of 999 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Avai Bio has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Avai Bio's Forward Dividend Yield % compare to IPM and RCT?
According to the Software industry distribution chart, Avai Bio ranks #999999 out of 999 companies for Forward Dividend Yield %. This places Avai Bio in the lower half of its industry. The industry median Forward Dividend Yield % is 2.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Software company?
The median Forward Dividend Yield % among Software companies is 2.55, based on 999 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Avai Bio and its competitors. For the Software industry, the median Forward Dividend Yield % is 2.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avai Bio's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avai Bio stock overvalued right now?
Avai Bio (AVAI) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. Avai Bio's overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Avai Bio (AVAI), the current Forward Dividend Yield % is 0.00% as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avai Bio Business Description

Address 5348 Vegas Drive, Las Vegas, NV, USA, 89108
Avai Bio Inc is a biotechnology company focused on identifying genetically modified cell lines, and through joint venture and licensing agreements, developing cell-based therapies. The company has two development programs in its cellular therapies pipeline, a diabetes development program to advance a treatment for type 1 and type 2 insulin-dependent diabetes, and an ?-Klotho protein development program to advance therapies for age-related diseases and anti-aging treatments.
24GF Score

Get the complete analysis for AVAI

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15
Price